Amlin PLC
13 June 2001
AMLIN PLC ('Amlin')
RESULTS OF AGM AND SCRIP DIVIDEND ALTERNATIVE OFFER
All of the Resolutions proposed at Amlin's AGM today were duly approved,
including a resolution to approve a long term incentive plan for underwriters
and those required to approve the offer of a Scrip Dividend Alternative to the
2000 final dividend of 2.6p per share. The latter offer, made in a circular to
shareholders dated 9 May 2001, is therefore now unconditional.
The Scrip Dividend Alternative was accepted in respect of 42,271,733 shares
which, at the reference price of 120.83p per share, will entitle the holders to
the issue of a total of 909,510 new ordinary shares of 25p each fully paid,
ranking, when issued, pari passu in all respects with Amlin's existing shares.
Application will be made to the UK Listing Authority and the London Stock
Exchange for these additional shares to be admitted to the Official List and to
trading. It is expected that such listing will become effective and that
dealings in the additional shares will commence on 3 July 2001.
13 June 2001
Enquiries:
Charles Pender 020 7746 1008
Secretary
Amlin plc
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.